Effect of Pumpkin Seed Oil on Hair Growth in Men With Androgenetic Alopecia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-02-29

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Androgenic alopecia is the most common cause of hair loss in men. Finasteride and minoxidil are available in treatment of androgenetic alopecia, although the former causes decreased libido or ejaculate volume, erectile dysfunction, the latter causes scaling, itching of the scalp. Recently, Pulpkin Seed Oil shows some improved clinical efficacy on scalp hair growth in men with androgenetic alopecia, but there is no evidence to support this.

The investigators conducted a randomized, double-blind, placebo-controlled efficacy and tolerability trial of Pumpkin seed oil (400mg/day)therapy in male patients with androgenetic alopecia.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss

NCT00151515

Androgenetic Alopecia

COMPLETED PHASE3

Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia

NCT02014584

Alopecia

COMPLETED PHASE3

Hair Growth Efficacy and Safety of NGF-574H in Adult With Androgenic Alopecia

NCT03676400

Androgenic Alopecia

COMPLETED NA

Nutraceutical Supplement With Standardized Botanicals in Males With Thinning Hair

NCT05339958

Hair Thinning

COMPLETED NA

A Safety and Efficacy Study of a Nutraceutical in Aging Males With Thinning Hair

NCT06854575

Hair Thinning

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Androgenic Alopecia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pumpkin Seed Oil

400mg/ day during 6 months

Group Type ACTIVE_COMPARATOR

400mg /day during 6 months

Intervention Type DIETARY_SUPPLEMENT

sweet potato starch

400mg/day during 6months

Group Type PLACEBO_COMPARATOR

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

400mg /day during 6 months

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 to 65 years of age
* Androgenetic alopecia of Norwood-Hamilton scale grade II-V

Exclusion Criteria

* Severe medical problems including renal problems, prostate diseases, diabetes mellitus o
* Patients who took any medicine which can affect the hair growth in recent 3 months.

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes